We are pleased about the vaccine efficacy of 95% in the overall population, particularly the over 94% disease protection in those over 65y and the benign safety profile observed, so far. These are critical milestones as we are discussing the data with the European Medicines Agency, FDA and many more regulatory authorities around the world.
The positive data readout is a testament to #mRNA as an emerging new drug class and the potential it could hold in pandemics and the treatment of life threatening diseases. As a global community, we are one step closer to having weathered the storm that is this pandemic and we believe that science will stem the tide. I would like to thank all women and men, my team BioNTech SE, our colleagues Pfizer and partners who have spent the last 10 months working tirelessly on a global project at the speed of light.
This shows what is possible when mankind works together, united to achieve a common goal.